Newbridge Financial Services Group’s Supernus Pharmaceuticals SUPN Stock Holding History

Newbridge Financial Services Group’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,000	Closed	-$63K	–	1382
2025 Q2	$63K	Hold	2,000	–	–	0.01%	461
2025 Q1	$65.5K	Hold	2,000	–	–	0.02%	322
2024 Q4	$72.3K	Buy	+2,000	New	+$70.4K	0.02%	326
2024 Q3	–	Sell	-2,000	Closed	-$53.5K	–	1055
2024 Q2	$53.5K	Hold	2,000	–	–	0.02%	362
2024 Q1	$68.2K	Hold	2,000	–	–	0.03%	344
2023 Q4	$57.9K	Hold	2,000	–	–	0.03%	363
2023 Q3	$55.1K	Sell	2,000 -1,000	-33%	-$30.4K	0.03%	392
2023 Q2	$90.2K	Hold	3,000	–	–	0.04%	337
2023 Q1	$109K	Hold	3,000	–	–	0.06%	305
2022 Q4	$107K	Hold	3,000	–	–	0.06%	289
2022 Q3	$102K	Hold	3,000	–	–	0.06%	297
2022 Q2	$87K	Hold	3,000	–	–	0.05%	287
2022 Q1	$97K	Hold	3,000	–	–	0.05%	312
2021 Q4	$87K	Hold	3,000	–	–	0.04%	343
2021 Q3	$80K	Hold	3,000	–	–	0.05%	301
2021 Q2	$92K	Hold	3,000	–	–	0.06%	297
2021 Q1	$79K	Hold	3,000	–	–	0.06%	297
2020 Q4	$75K	Hold	3,000	–	–	0.06%	256
2020 Q3	$63K	Buy	+3,000	New	+$68.1K	0.06%	270

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Newbridge Financial Services Group's SUPN Position: Q3 2025 in Review

Newbridge Financial Services Group sold out of Supernus Pharmaceuticals (SUPN) in Q3 2025, closing a stake of 2,000 shares — an estimated $63K sold.

Newbridge Financial Services Group first reported a position in SUPN in Q3 2020 and held it in 19 quarters. The position peaked at $109K in Q1 2023. 310 funds tracked by Wall St. Rank hold SUPN as of Q3 2025.

Newbridge Financial Services Group reported no remaining Supernus Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
Newbridge Financial Services Group sold 2,000 Supernus Pharmaceuticals shares in Q3 2025, an estimated $63K.
Newbridge Financial Services Group first reported a position in Supernus Pharmaceuticals in Q3 2020 and held it in 19 quarters.
Newbridge Financial Services Group's Supernus Pharmaceuticals position peaked at $109K in Q1 2023.
310 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2025.

Based on Newbridge Financial Services Group's 13F filing for Q3 2025, filed 13 Nov 2025.